Life Sciences

This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.

Increased competition between healthcare providers which has lead to increased development of competitive features, such as premium care facilities, aesthetic and wellness medicine facilities, improved patient customer service, and so on. This has also stimulated the increased application of technology in both medical devices and information and c...

The infectious disease IVD market in Indonesian presents diversified growth potential for different tiers of participants. Domestic participants stand to gain from the growth momentum in the lower-end market, whereas foreign leading manufacturers dominate the higher-end market. This research service analyses the infectious disease IVD market and p...

The global generics industry is in an interesting phase. Prescription volumes for generics are rising in the US and European markets, while regional manufacturers are struggling to meet demand. However, while Asian prescription volumes are lower than that of Western markets, Asian manufacturers are catering to domestic markets and exporting a signi...

This study provides data for the Russian in vitro diagnostics (IVD) market. Hematology, hemostasis (coagulation), urinalysis, microbiology, clinical chemistry, point of care testing, molecular diagnostics, immunochemistry, and others namely, tissue diagnostics and self-monitoring blood glucose, are the segments discussed in this market. Market reve...

This study provides market data for the Russian hematology diagnostics market. Segments in the market include instruments and reagents. Instruments are further segmented by 5PD and 3PD analyzers. Market revenues, installed base units, and market share are included in this deliverable. Further analysis is provided in a separate deliverable to accomp...

This study provides market data for the Russian urinalysis market. Market segments include sediment, dipstick, and integrated systems. Sediment and dipstick segments are further segmented by instruments and reagents. Integrated systems is further segmented by instruments. In this deliverable, market revenues, installed base units, and market share ...

This study provides market data for the Russian hemostasis diagnostics market. Market segments include instruments and reagents. The study also includes market revenues, installed base units, and market share for hemostasis diagnostics. Further analysis is provided in a separate deliverable to accompany this data. The timeframe for this study is 20...

Healthcare expenditure in Asia-Pacific is expected to continue growing over the next 6 years, as rising demand for better healthcare for patients spurs reforms. This would also increase life expectancy, resulting in a large elderly population requiring long-term care. This study covers the hospital, life sciences, advanced medical technology, and c...